Inspire Investing LLC Has $1.28 Million Stock Position in Cabot Co. (NYSE:CBT)

Inspire Investing LLC boosted its stake in Cabot Co. (NYSE:CBT - Free Report) by 202.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,462 shares of the specialty chemicals company's stock after purchasing an additional 7,671 shares during the quarter. Inspire Investing LLC's holdings in Cabot were worth $1,281,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Virtu Financial LLC acquired a new stake in shares of Cabot in the 4th quarter valued at $258,000. Quadrature Capital Ltd grew its position in Cabot by 267.3% in the fourth quarter. Quadrature Capital Ltd now owns 11,380 shares of the specialty chemicals company's stock valued at $950,000 after acquiring an additional 8,282 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in Cabot during the fourth quarter worth about $557,000. Los Angeles Capital Management LLC lifted its holdings in shares of Cabot by 1.4% in the first quarter. Los Angeles Capital Management LLC now owns 10,851 shares of the specialty chemicals company's stock worth $1,000,000 after acquiring an additional 145 shares during the last quarter. Finally, Banque Cantonale Vaudoise boosted its stake in shares of Cabot by 17.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 833 shares of the specialty chemicals company's stock valued at $77,000 after purchasing an additional 124 shares in the last quarter. Institutional investors own 93.18% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $95.00 to $105.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 7th. UBS Group lowered their price target on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a report on Tuesday, August 6th. Finally, StockNews.com downgraded Cabot from a "strong-buy" rating to a "buy" rating in a report on Monday, June 24th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $101.75.

Insider Activity

In related news, CFO Erica Mclaughlin sold 23,274 shares of the company's stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now directly owns 59,814 shares in the company, valued at $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the company's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares of the company's stock, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares of the company's stock, valued at approximately $10,194,240. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 71,939 shares of company stock valued at $7,308,812. Company insiders own 3.07% of the company's stock.

Cabot Trading Up 1.3 %

CBT traded up $1.42 during trading on Monday, reaching $113.83. 169,546 shares of the company's stock were exchanged, compared to its average volume of 335,100. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. Cabot Co. has a one year low of $65.10 and a one year high of $114.13. The firm has a fifty day moving average price of $104.12 and a two-hundred day moving average price of $98.99. The stock has a market capitalization of $6.29 billion, a PE ratio of 14.23, a price-to-earnings-growth ratio of 0.93 and a beta of 1.19.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.20. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. Cabot's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.42 earnings per share. As a group, equities research analysts forecast that Cabot Co. will post 7.07 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.